A secret shopper survey conducted by researchers at Yale University and published this week in the Journal of the American Medical Association offers an alarming, if unsurprising, glimpse into the world of telehealth purveyors of GLP-1 medicines. It confirms what doctors have worried about for years: The popular obesity drugs are being cavalierly prescribed. It should be yet another wake-up call f
Science Bloomberg Jul 7, 2026